No categories for this tab

About Us

About PharmaCountry
How It Works
Partnerships
Sustainability
Contact Us

For Buyers

Search Products
Search Services
Find Suppliers
Find Jobs
Find Seekers
Help Center
FAQ
Buyer Protection

For Sellers/Service Providers

Start Selling
Seller Guide
Pricing Plans
Advertising
Seller Support

Top Categories

Active Pharmaceutical Ingredients (APIs)
Finished Dosage Forms
Manufacturing Equipment & Utilities
Excipients & Additives
View All Categories

Stay Connected

[email protected]

24/7 Customer Support

Trusted B2B Platform

SSL Secure Transactions Verified Suppliers Quality Assured B2B Certified Global Network

© 2026 PharmaCountry. All rights reserved.

Privacy Policy Terms of Service Cookie Policy

NIVESTIM 48 MU/0,5 ml SOLUCION INYECTABLE O PARA PERFUSION | Pharmacountry

Products
Finished Dosage Forms
Injectables & Parenterals
Small Volume Parenterals (SVP)

NIVESTIM 48 MU/0,5 ml SOLUCION INYECTABLE O PARA PERFUSION

PE

PFIZER EUROPE MA EEIG

Marketing Authorization Holder · Finished Dosage FormsBelgium

Basic Information

Category

Subcategory & Sub-subcategory

/

Trade Type

Sell

Product Name

NIVESTIM 48 MU/0,5 ml SOLUCION INYECTABLE O PARA PERFUSION

Details

Substance

Registered Market

Distributor(s)

- .

Specifications

Dosage Form: Injection
ATC Code: L03AA02
Packaging: NIVESTIM 48 MU/0,5 ml solution for injection O for infusion, 5 pre-filled syringes of 0,5 ml

Documents

Drug Marketing Authorization Number

Document No.: 110631008

Issue Date: Oct 18, 2010

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product

Finished Dosage Forms

Injectables & Parenterals

Small Volume Parenterals (SVP)

FILGRASTIM 48 MILLONES UI

Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológic